Carol D Weiss

Title: Carol D. Weiss: Innovating in HIV Research

Introduction: Carol D. Weiss, based in Bethesda, MD, is a distinguished inventor with a focus on advancing the understanding and treatment of HIV. With her innovative approach, she has contributed significantly to the field of immunology, specifically in the development of strategies to elicit neutralizing antibodies against HIV.

Latest Patents: Carol D. Weiss holds one notable patent titled "Methods of eliciting broadly neutralizing antibodies targeting HIV-1 gp41." This patent centers on the induction and characterization of a humoral immune response targeting 'entry-relevant' gp41 structures of HIV. The invention seeks to raise a neutralizing antibody response that encompasses a broad spectrum of HIV strains, thereby aiming to reduce or inhibit the virus's ability to infect healthy cells. The methods described in this patent hold potential for use as therapeutic tools and for enhancing the understanding of HIV's cell entry mechanisms.

Career Highlights: Throughout her career, Carol has made significant contributions while working for reputable organizations, including the Government of the United States, represented by the Secretary of the Department of Health and Human Services, and Panacos Pharmaceuticals, Inc. Her work in these institutions has allowed her to collaborate on critical research that bridges science and practical applications.

Collaborations: Carol has had the privilege of working alongside esteemed colleagues, including Carl Thomas Wild. This collaboration has undoubtedly enriched her research endeavors, allowing for a comprehensive approach to tackling the challenges posed by HIV.

Conclusion: Carol D. Weiss's innovative contributions to the field of HIV research reflect her dedication to improving health outcomes. Her work in eliciting broadly neutralizing antibodies not only represents a significant step forward in immunology but also illustrates the vital role of inventors in shaping the future of medical science.